135 related articles for article (PubMed ID: 37042161)
21. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
22. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies.
Shen A; Lu Q; Fu X; Wei X; Zhang L; Bian J; Qiang W; Pang D
Support Care Cancer; 2022 Dec; 31(1):18. PubMed ID: 36513801
[TBL] [Abstract][Full Text] [Related]
23. Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Hillyer GC; Chen L; Hershman DL
Breast Cancer Res Treat; 2016 Jul; 158(2):373-84. PubMed ID: 27365080
[TBL] [Abstract][Full Text] [Related]
24. Bilateral Changes in Deep Tissue Environment After Manual Lymphatic Drainage in Patients with Breast Cancer Treatment-Related Lymphedema.
Donahue PM; Crescenzi R; Scott AO; Braxton V; Desai A; Smith SA; Jordi J; Meszoely IM; Grau AM; Kauffmann RM; Sweeting RS; Spotanski K; Ridner SH; Donahue MJ
Lymphat Res Biol; 2017 Mar; 15(1):45-56. PubMed ID: 28323572
[TBL] [Abstract][Full Text] [Related]
25. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.
Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S
Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508
[TBL] [Abstract][Full Text] [Related]
26. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
27. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
28. Can the dissection device with low thermal injury prevent breast cancer-related arm lymphedema? A retrospective cohort study.
Takuwa H; Izaki E; Yamashiro H; Takeuchi M
Asian J Surg; 2021 Sep; 44(9):1220-1221. PubMed ID: 34193385
[No Abstract] [Full Text] [Related]
29. Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lin Y; Yang Y; Zhang X; Li W; Li H; Mu D
Clin Breast Cancer; 2022 Jul; 22(5):e664-e673. PubMed ID: 35370085
[TBL] [Abstract][Full Text] [Related]
30. Current puzzles presented by postmastectomy oedema (breast cancer related lymphoedema).
Stanton AW; Levick JR; Mortimer PS
Vasc Med; 1996; 1(3):213-25. PubMed ID: 9546940
[No Abstract] [Full Text] [Related]
31. Association between Immediate Breast Reconstruction and the Development of Breast Cancer-Related Lymphedema.
Jeon HB; Jung JH; Im SH; Kim YB; Chang JS; Song SY; Lew DH; Roh TS; Lee WJ; Lee DW
Plast Reconstr Surg; 2023 Feb; 151(2):214e-222e. PubMed ID: 36696309
[TBL] [Abstract][Full Text] [Related]
32. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
Farley CR; Irwin S; Adesoye T; Sun SX; DeSnyder SM; Lucci A; Shaitelman SF; Chang EI; Ueno NT; Woodward WA; Teshome M
Ann Surg Oncol; 2022 Oct; 29(10):6370-6378. PubMed ID: 35854031
[TBL] [Abstract][Full Text] [Related]
33. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
Brunelle CL; Roberts SA; Shui AM; Gillespie TC; Daniell KM; Naoum GE; Taghian A
J Surg Oncol; 2020 Aug; 122(2):155-163. PubMed ID: 32497273
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions.
Brahma B; Yamamoto T
Eur J Surg Oncol; 2019 Jul; 45(7):1138-1145. PubMed ID: 30638810
[TBL] [Abstract][Full Text] [Related]
35. Precipitating factors for lymphedema following surgical treatment of breast cancer: implications for patients undergoing axillary lymph node dissection.
Dayangac M; Makay O; Yeniay L; Aynaci M; Kapkac M; Yilmaz R
Breast J; 2009; 15(2):210-1. PubMed ID: 19292814
[No Abstract] [Full Text] [Related]
36. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer-related lymphedema rates after modern axillary treatments: How accurate are our estimates?
Cortina CS; Yen TWF; Bergom C; Fields B; Craft MA; Currey A; Kong AL
Surgery; 2022 Mar; 171(3):682-686. PubMed ID: 34736790
[TBL] [Abstract][Full Text] [Related]
38. Advances in the prevention and treatment of breast cancer-related lymphedema.
Donahue PMC; MacKenzie A; Filipovic A; Koelmeyer L
Breast Cancer Res Treat; 2023 Jul; 200(1):1-14. PubMed ID: 37103598
[TBL] [Abstract][Full Text] [Related]
39. Lymphedema in breast cancer patients: declining, but awareness still needed.
J Support Oncol; 2006 Feb; 4(2):71. PubMed ID: 16499122
[No Abstract] [Full Text] [Related]
40. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
